Traws Pharma, Inc. (TRAW) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US68232V8845
Traws Pharma, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.79 m USD |
| Operating income | -17.88 m USD |
| EBIT | 8.72 m USD |
| Net income | 9.17 m USD |
| Diluted EPS – continuing operations | 0.82 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Traws Pharma, Inc.
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It is also developing narazaciclib, a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib, which is administered alone or in combination for investigation in various cancers. It has a license agreement with SymBio Pharmaceuticals Limited, Pint International SA, Viriom, Inc., Knight Therapeutics Inc., Specialised Therapeutics Asia Pte. Ltd., and Temple University. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
More stocks
- CaliberCos Inc. (CWD)
- TaoWeave, Inc. (TWAV)
- Knightscope, Inc. (KSCP)
- CYANOTECH CORP (CYAN)
- Twin Vee PowerCats, Co. (VEEE)
- Aclarion, Inc. (ACON)
- Liminatus Pharma, Inc. (LIMN)
- OLB GROUP, INC. (OLB)
- SUIC Worldwide Holdings Ltd. (SUIC)
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
- Perfect Moment Ltd. (PMNT)
- Global Innovative Platforms Inc. (GIPL)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.